Biocryst Pharmaceuticals Inc.
BCRX
Market Cap$1.74B
Close$
$7.62
7.9% downside
Current Fair Value
7.9% downsideOvervalued by 7.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.74 Billion |
|---|---|
| Enterprise Value | $2.39 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.43 |
| Beta | 1.1 |
| Outstanding Shares | 209,203,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -48.68 |
|---|---|
| PEG | 34.74 |
| Price to Sales | 4.14 |
| Price to Book Ratio | -2.76 |
| Enterprise Value to Revenue | 4.3 |
| Enterprise Value to EBIT | -30.44 |
| Enterprise Value to Net Income | -68 |
| Total Debt to Enterprise | 0.31 |
| Debt to Equity | -1.75 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Biocryst Pharmaceuticals Inc.
CEO: Jon Stonehouse